Catalyst Pharmaceuticals (CPRX) Capital Expenditures (2011 - 2026)
Catalyst Pharmaceuticals posted quarterly Capital Expenditures of $27000.0 for Q1 2026, down 15.62% on a QoQ basis from $32000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 13 years of Capital Expenditures data on file, last reported at $27000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures changed N/A year-over-year to $27000.0; the trailing twelve-month figure through Mar 2026 stood at $85000.0 (down 76.19% YoY), and the FY2025 full-year result was $58000.0, down 89.57% from the prior year.
- Capital Expenditures for Q1 2026 stood at $27000.0, down from $32000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $259000.0 in Q3 2024 and bottomed at $10000.0 in Q2 2024.
- The 4-year median for Capital Expenditures is $69000.0 (2023), against an average of $87200.0.
- The widest annual swing landed in 2024, when Capital Expenditures jumped 304.69%; it then sank 63.64% in 2025.
- A 4-year view of Capital Expenditures shows it stood at $93000.0 in 2023, then slipped by 5.38% to $88000.0 in 2024, then tumbled by 63.64% to $32000.0 in 2025, then declined by 15.62% to $27000.0 in 2026.
- The last three Capital Expenditures figures came in at $27000.0 (Q1 2026), $32000.0 (Q4 2025), and $26000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 199,000.00 |
| Mar 31, 2024 | 199,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 74,000.00 |
| Mar 31, 2023 | 74,000.00 |
| Dec 31, 2021 | 41,000.00 |
| Dec 31, 2021 | 41,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 911,000.00 |
| Mar 31, 2021 | 911,000.00 |
| Dec 31, 2019 | -370.00 |
| Dec 31, 2019 | -370.00 |
| Jun 30, 2019 | 13,737.00 |
| Jun 30, 2019 | 13,737.00 |
| Mar 31, 2019 | 5,633.00 |
| Mar 31, 2019 | 5,633.00 |
| Dec 31, 2018 | 56,825.00 |
| Dec 31, 2018 | 56,825.00 |
| Sep 30, 2018 | 23,256.00 |
| Sep 30, 2018 | 23,256.00 |
| Jun 30, 2018 | 11,937.00 |
| Jun 30, 2018 | 11,937.00 |
| Dec 31, 2016 | 7,130.00 |
| Dec 31, 2016 | 7,130.00 |
| Sep 30, 2016 | 2.00 |
| Sep 30, 2016 | 2.00 |
| Sep 30, 2015 | 14,425.00 |
| Sep 30, 2015 | 14,425.00 |
| Jun 30, 2015 | 1,130.00 |
| Jun 30, 2015 | 1,130.00 |
| Mar 31, 2015 | 7,910.00 |
| Mar 31, 2015 | 7,910.00 |
| Dec 31, 2014 | 13,896.00 |
| Dec 31, 2014 | 13,896.00 |
| Sep 30, 2014 | 13,119.00 |
| Sep 30, 2014 | 13,119.00 |
| Jun 30, 2014 | 13,002.00 |
| Jun 30, 2014 | 13,002.00 |
| Mar 31, 2014 | 17,306.00 |
| Mar 31, 2014 | 17,306.00 |
| Jun 30, 2013 | -1.00 |
| Jun 30, 2013 | -1.00 |
| Mar 31, 2013 | 9,433.00 |
| Mar 31, 2013 | 9,433.00 |
| Dec 31, 2012 | 45,500.00 |
| Dec 31, 2012 | 45,500.00 |
| Sep 30, 2012 | 1.00 |
| Sep 30, 2012 | 1.00 |
| Jun 30, 2012 | 1,900.00 |
| Jun 30, 2012 | 1,900.00 |
| Mar 31, 2012 | 4,981.00 |
| Mar 31, 2012 | 4,981.00 |
| Dec 31, 2011 | 1,820.00 |
| Dec 31, 2011 | 1,820.00 |